Guide
Life science intelligence: the data foundation that gets therapies to patients
Pharma has invested billions in AI, cloud platforms, and point solutions. Life science intelligence is the shared data foundation that connects those investments, running from discovery through post-market with GxP compliance built in. This guide shows how to build it without a multi-year overhaul.
Download the guide
estimated worth in pulled-forward revenue for every week saved in late-stage clinical development.
Where pharma's data investments are stalling
R&D teams model proteins with AI while commercial supply chains track living cell therapies on spreadsheets. Clinical submissions stall on manual document reconciliation while manufacturing deviations sit locked in CDMO portals as unstructured PDFs. Pharma spends hundreds of billions annually on IT globally.
The issue is architecture: organizations have optimized each function in isolation, creating rigid silos that require humans to act as middleware. The result is Pilot Purgatory, where AI initiatives work on clean static extracts but fail in production because the data foundation can’t support them.
What’s inside the blueprint
- The modern life sciences lifecycle and why traditional architectures can't keep up How the shift from small molecules to biologics, cell and gene therapies, and decentralized clinical trials has made fragmented architectures a direct patient risk, not just an IT problem.
- The case for a unified intelligence platformWhat it means to connect discovery, clinical, manufacturing, and commercial data into a continuous feedback loop, and how real-world evidence locked in post-market reporting can inform the next trial's inclusion criteria.
- Life science intelligence in action What the platform delivers across each stage: faster hypothesis generation in discovery, adaptive trial design in clinical, real-time batch monitoring in CMC, Compliance-as-Code in regulatory, and AI-driven commercial execution post-launch.
- The blueprint for life sciences leaders: the phData Forge™ delivery model A three-step delivery model built for regulated environments: advisory and use case ideation, a single Forge™ sprint that delivers a production-ready data product in four weeks, and sprint-by-sprint scale across R&D, Clinical, and Commercial.
Ready to download?
Get the guide now.
What life science intelligence actually requires
Building this means layering a governed, GxP-compliant foundation on top of what clients already have: Snowflake, Veeva, and existing EDC and LIMS systems. phData Forge™ delivers it sprint by sprint, each producing a production-ready data product in four weeks.
A missed manufacturing slot is a lost therapy for a patient with no time to spare.
Frequently asked questions
What is life science intelligence?
Life science intelligence is the organizational capability to continuously translate data from every stage of the pharmaceutical lifecycle into decisions that reduce risk and speed patient access. It requires a unified data architecture: a shared, governed intelligence layer that connects previously siloed systems across discovery, clinical, manufacturing, and commercial rather than optimizing each function in isolation.
Why do pharma organizations get stuck in Pilot Purgatory?
Pilot Purgatory describes the pattern where AI pilots succeed on clean data extracts but fail when deployed to production. The cause is almost always a fragile data foundation: real-time data streams are messy, systems use incompatible data models, and GxP validation requirements aren’t built into the architecture from the start. A shared data foundation is the fix.
What is Compliance-as-Code and why does it matter in life sciences?
Compliance-as-Code is an architectural approach that embeds GxP validation, data lineage tracking, and audit trail generation directly into the data platform, instead of applying compliance as a manual, post-hoc documentation layer. Every data point becomes inherently traceable and explainable, cutting regulatory response cycles and reducing the manual reconciliation burden on clinical and quality operations teams.
What life science intelligence use cases should pharma organizations prioritize first?
phData recommends starting where data friction is most acute and most measurable: regulatory submission readiness, manufacturing batch release, or commercial supply chain visibility. Each has clear economic stakes, a defined data scope, and an existing Snowflake environment to deploy into. A single Forge™ sprint validates the architecture and proves economic value before broader investment.
How are you building your life science intelligence platform?
Download the guide, or talk to us about scoping your first use case.